Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000908733-08-000118
Filing Date
2008-01-22
Accepted
2008-01-22 16:10:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIOMARIN PHARMACEUTICAL INC 13G biomarinpharmaceuticalinc.htm SC 13G 11762
  Complete submission text file 0000908733-08-000118.txt   13968
Mailing Address 227 W MONROE ST STE 3000 CHICAGO IL 60606
Business Address 227 W MONROE STREET SUITE 3000 CHICAGO IL 60606 3126349231
COLUMBIA WANGER ASSET MANAGEMENT LP (Filed by) CIK: 0000908733 (see all company filings)

EIN.: 363820584 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Subject) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-56595 | Film No.: 08542029
SIC: 2834 Pharmaceutical Preparations